Outlook Therapeutics Inc

OTLKNASDAQ NMS - GLOBAL MARKET

Health CareBiotechnology

$0.7300

-0.010000 (-1.35%)

As of 05/29/26 EDT · USD

Compare

52-Week Low: $0.1600Current: $0.730052-Week High: $3.39

Key Statistics

Open

$0.7500

Day High

$0.8200

Day Low

$0.6848

Prev. Close

$0.7400

Volume

26.86M

Avg. Volume

—

Market Cap

$88.23M

P/E (TTM)

-0.58

Forward P/E

—

P/B Ratio

—

52W High

$3.39

52W Low

$0.1600

50D MA

$0.2849

200D MA

$0.9553

Dividend Yield

—

Beta

—

Performance

+119.2%

+184.7%

-54.4%

YTD

+10.6%

-60.3%

About

This list of pharmaceutical compound number prefixes provides codes used by individual pharmaceutical companies when naming their pharmaceutical drug candidates. Pharmaceutical companies generally produce large numbers of compounds in the research phase for which it is impractical to use often long and cumbersome systematic chemical names, and for which the effort to generate nonproprietary names may not be warranted, see article on drug nomenclature. Instead, these compounds are usually given a number for internal reference at the company. To distinguish the numbered compounds from different companies, each compound number is prefixed with a letter code indicating the company that developed the compound, that claims intellectual property on that compound etc. The letter code is conceived by companies themselves who should be interested in creating a unique code. Three main methods are found for prefixing the numeric identifier – with a space (gap), with nothing (concatenated), and with a dash.

outlooktherapeutics.com/